NIMH Outreach Partnership Program Description
The Outreach Partnership Program is a nationwide initiative of the National Institute of Mental Health’s (NIMH) Office of Constituency Relations and Public Liaison (OCRPL). The Program works to increase the public’s access to science-based mental health information through partnerships with national and state nonprofit organizations. The Program has a particular emphasis on reaching historically underserved populations. The Program also strives to enhance opportunities for the public to benefit from participation in research. These partnerships provide NIMH with the opportunity to engage community organizations in dialogue to better understand the needs, questions, and concerns of those intended to benefit from the research the Institute supports.
The Outreach Partnership Program is vital to NIMH’s efforts to deliver science-based information to communities across the country. Specifically, the Program is designed to:
• Foster more widespread understanding about mental disorders, the brain, and behavior, thereby helping to reduce misperceptions and negative attitudes towards mental illness;
• Increase awareness of the role of basic, translational, and clinical research in the understanding, prevention, and treatment of mental illnesses; and
• Increase awareness about the opportunities to benefit from participation in mental health research.
There are 55 Outreach Partner organizations representing all states, the District of Columbia, and Puerto Rico. Outreach Partners disseminate NIMH research findings and educational materials to the public throughout their states and local communities, including families and individuals affected by mental illness, healthcare professionals, underserved populations, and other constituencies such as schools, social service agencies, and faith-based organizations. Outreach Partners also conduct targeted outreach activities to address mental disorders among children and adolescents and other populations identified to be at-risk, and mental health disparities that occur because of race, ethnicity, age (e.g., older adults), education, income, disability status, geographic location, or risk status related to sex and gender. In addition, Outreach Partners promote volunteer participation in NIMH and NIHclinical trials and often collaborate with researchers to advance the research process. Learn more about what Outreach Partners are doing to address mental health disparities and increase awareness about mental disorders during childhood and adolescence.
Outreach Partners are selected through a competitive process and serve three-year terms. Benefits provided to these organizations include an annual stipend, sponsored participation in an annual meeting, the biweekly electronic Update newsletter featuring the latest Federal news and resources related to mental health, and access to NIMH scientific and educational publications for mass dissemination. Partners are able to network among themselves and with Federal, national, and state organizations through the annual meetings and a dedicated electronic mailing list.
Here is a listing of NIMH publications available from the NAMI Connecticut office. Call the NAMI Connecticut office at 860-882-0236 to ask for brochures or send an email to email@example.com
If large quantities of publications are desired, please make arrangements to come and pick them up at the NAMI Connecticut office.
Note that we have a limited quantity of some publications. In that case you will only receive one copy of the publication.
English NIMH Publications
- Bipolar Disorder in Adults
- Bipolar Disorder
- Depression In Women – Discovering Hope
- Borderline Personality Disorder
- Eating Disorders
- Generalized Anxiety Disorder (GAD)
- Obsessive-Compulsive Disorder (OCD)
- Panic Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Social Phobia
- Mental Health Medications
- A Participant’s Guide to Mental Health Clinical Research
- Older Adults and Depression
- Men and Depression
- Chronic Illness and Mental Health: Recognizing and Treating Depression
- Neuroimaging and Mental Illness: A Window Into the Brain
- Postpartum Depression Facts
Children, Adolescent and Young Adult NIMH Publications
- Attention Deficit Hyperactivity Disorder (ADHD)
- A Parent’s Guide to Autism Spectrum Disorder
- Autism Spectrum Disorder
- Bipolar Disorder in Children and Teens
- Treatment of Children with Mental Illness
- Helping Children and Adolescents Cope with Violence and Disasters:
- What Community Members Can Do
- What Rescue Workers Can Do
- What Parents Can Do
- Suicide - Facts about suicide and suicide prevention among teens and young adults
- The Teen Brain: Still Under Construction
- Depression and High School Students
- Depression and College Students
- Teen Depression: You are not alone. There are ways you can feel better.
Spanish NIMH Publications
- Las Mujeres y la depresión – Descubriendo La Esperanza
- Los hombres y la depresión
- Trastorno de Ansiedad Generalizada (GAD)
- Trastorno de Comportamiento Obsesivo Compulsivo (OCD)
- Trastorno de Pánico
- Trastorno de Estrés Postraumático (PTSD)
- Fobia Social
- La Enfermedad de Alzheimer
- Trastornos de Ansiedad
- Transtorno Bipolar
- Transtorno Biploar en Ninos y Adolescentes
- Transtorno do Deficit de Atencion e Hiperactividad
- Trastornos de la Alimentación
- Personas Mayores y la Depresión
- Estos hombres son reales. La depresión también.
- El Suicidio en los Estados Unidos de América
- Depresión y el VIH/SIDA
- Depresión y la Diabetes
- Depresión y el Accidente Cerebrovascular
- Depresión y la Enfermedad Cardíaca
- Guía para los Participantes - sobre Investigaciones Clínicas de la Salud Mental
- Tratamiento de Niños con Enfermedades Mentales
- Ayudando a Niños y Adolescentes a Superar la Violencia y los Desastres:
- Que Pueden Hacer los Trabajadores del Cuerpo de Rescate
- Que Pueden Hacer los Miembros de la Comunidad
- Que Pueden Hacer los Padres
Would you like to participate in a Research Study? Check out the following from NIMH and others:
Nationwide Recruitment: Major Depression and AV101
Join a Research Study: Enrolling nationally from around the country
The primary purpose of this research study is to evaluate the safety and effectiveness of the oral drug AV-101 (an antagonist of the glycine receptor) versus placebo. The study aims to determine if this experimental drug has antidepressant effects and fewer side effects than other novel treatments for depression.
We are enrolling moderately depressed individuals between the ages of 18 and 65 with hard-to-treat major depressive disorder. This inpatient study lasts up to 14 weeks and procedures include a medication taper, taking the research drug, taking placebo and 4 brain imaging scans. Optional procedures include a lumbar puncture and catheter placement in the spine two times. After completing the study, participants receive short-term follow-up care at the NIH while transitioning back to a provider.
The study is conducted at the NIH Clinical Center in Bethesda, Maryland and enrolls eligible participants from across the USA. Travel arrangements are provided and costs are covered by NIMH (arrangements vary by distance). There is no cost to participate and compensation is provided.
The first steps to participate include calling NIMH, learning specifics about the study, asking about your eligibility, and consenting to participate.
To find out if you qualify, send an email to firstname.lastname@example.org, or call 1-877-646-3644 (1-877-MIND-NIH) [TTY: 1-866-411-1010].
University of Maryland Research Study.
Have you ever been diagnosed with some form of clinical depression (including, but NOT limited to, major depressive disorder, bipolar disorder, dysthymia, and others)? Are you currently employed? Are you interested in helping researchers to better understand YOUR experiences at work? And finally, would you like to earn $20.00? Then please take our online survey (approx. 30 minutes long) concerning disclosure of depression diagnosis at work. This survey is ANONYMOUS and we will not be able to identify you by your answers. Read More...
MoodNetwork: Join the study to find better treatments for depression and bipolar disorder. If you're one of the millions of people who struggle with depression or bipolar disorder, you know how hard it can be to live with these conditions and how frustrating it can be to find effective treatments. You know how isolated you can feel in a world that still doesn’t understand or accept mood disorders. If you are someone who has found ways to live successfully with a mood disorder, you have invaluable knowledge and experience that can help others. Read More...
Yale Study for Anxiety in Autism.
Does Your Child Have Autism and Anxiety? The Yale Child Study Center is seeking participants for a study of cognitive-behavioral therapy for anxiety in children with high functioning autism.
- Anxiety can include symptoms such as fears, feeling tense, being nervous or worrying too much.
- Cognitive-behavioral therapy teaches strategies for dealing with anxiety and consists of 15 weekly sessions conducted with the child and his or her parent.
Participants receive free assessment, free therapy and up to $350 for participation.
Yale Child Study Center Program for Anxiety Disorders
Yale Child Study Center Program for Anxiety Disorders. The Program for Anxiety Disorders at the Yale Child Study Center is recruiting children and parents to participate in research studies. Come help them learn about the causes and treatment of childhood anxiety. They are looking for children with all levels of anxiety, including youth with no anxiety, some anxiety, and severe anxiety disorders. Participants receive either paid compensation or treatment free of charge. Read More...
Yale University STEP-ED Study: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.
Purpose: The guiding questions for this study are: can a U.S. adaptation of a successful Scandinavian approach to early detection substantially reduce the duration of untreated psychosis (DUP) and improve outcomes beyond an established first-episode service (FES)?
The primary aim of this study is to determine whether an early detection intervention can reduce the duration of untreated psychosis in the US, as compared to usual detection; as well as to determine whether the duration of untreated psychosis reduction can augment the outcomes of established 'first-episode' services on outcomes in the U.S. The investigators will measure symptoms, functioning and engagement with treatment at entry and over 1 year at each site.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.
Ages Eligible for Study: 16 Years to 35 Years
Contacts: Philip Markovich, B.A. 203-974-7043, email@example.com
Please refer to this study by its ClinicalTrials.gov identifier: NCT02069925
New UCONN Zonisamide study
Would you like to reduce or stop your drinking? Volunteers Needed for Research Study.
- Women and men ages 21-70 are needed for a 16-week alcohol medication treatment study at UConn Health in Farmington.
- The study medication (active drug or inactive placebo) and study visits are free.
- Receive up to $950 for completion of the entire study and all follow-up visits.
For further information, please call 860-679-6730. All calls are confidential.
UConn Health Center Study Recruiting Research Subjects
UConn Health Center Study Recruiting Research Subjects. Are You Feeling Sad or Blue? Have You Lost Interest In Activities or People You Once Enjoyed? Neurobiology and Acute Treatment Outcome of Late Life Depression Study. Men and women 60 years old or older who are experiencing symptoms of depression are needed for this study to investigate depression in older adults and how older adults respond to stress.
Yale/VA Research Study
Yale/VA Research Study. Wanted: healthy people who have a family history of schizophrenia or schizoaffective disorder, as well as individuals with schizophrenia or schizoaffective disorder. Participants who qualify will receive a stipend. Click the links above for more information, or call: (203) 932-5711, ext. 4525.
VABHS Is Looking for Study Participants
The VA Boston Healthcare System is working on a genetics study related to schizophrenia.
The Boston VA Research Institute's genetics study related to schizophrenia is still underway. They’re searching for families with a history of schizophrenia and related disorders. Families can come from anywhere in the U.S. Their research team visits all study subjects in their home to conduct a clinical interview. Arrangements are made to have a blood draw done at a lab located conveniently nearby. Participants who complete the study receive a stipend of $130.00. Read More
YALE RESEARCH STUDIES ON SCHIZOPHRENIA.
Yale Research is interested in cognitive neuroscience of psychiatric illness. We seek to better understand, at the neural system level, the mechanisms behind cognitive and affective deficits in neuropsychiatric illness. Specifically, the research in our group focuses on understanding these processes in schizophrenia, bipolar illness and addiction. We use a combination of tools to better understand the underlying systems involved in processing affective stimuli and their interaction with circuits involved in goal-directed cognitive operations such as working memory. See below for more info:
HAVE YOU BEEN DIAGNOSED WITH SCHIZOPHRENIA?
We are conducting brain imaging studies using state of the art neuroimaging techniques. We are recruiting adults who may meet diagnostic criteria for schizophrenia.
You might qualify if you meet the following criteria:
1. Age 18-55
2. No major medical illness
3. Not diagnosed with depression
4. Not using drugs, or consuming a lot of alcohol
- This study lasts up to 2 weeks and will take up to 10 hours to complete.
- Study will include a fMRI scan, blood test and interviews.
- Compensation is provided for your participation.
Contact: Nicole P. Santamauro, M.A.
Research Project Coordinator
Yale University School of Medicine
Department of Psychiatry
NATIONWIDE RECRUITMENT: DEPRESSION ADULT RESEARCH STUDY
RAPID ANTIDEPRESSANT EFFECTS OF KETAMINE
Individuals who have been diagnosed with major depression may be able to participate in a trial designed to understand the causes of depression and rapid antidepressant response. Specifically, NIMH is testing whether ketamine, a drug that affects glutamate in the brain, will improve symptoms of depression within a matter of hours.
Individuals who are 18-65 years of age and have been diagnosed with major depression (unipolar) and previously failed to respond to treatment may be eligible for an inpatient study designed to bring about a rapid antidepressant effect.
After completion of the study the participant is transitioned back to a clinician in the community. All research participation is without cost and NIMH will cover all transportation costs from anywhere in the United States. Compensation is provided for study procedures.
For more information, please call 1-877-MIND-NIH (1-877-646-3644) or firstname.lastname@example.org.
National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services
For more information on research conducted by the NIMH in Bethesda, MD click here http://patientinfo.nimh.nih.gov.
Research study on memory, attention and problem solving in psychiatric illnesses.
The Olin Neuropsychiatry Research Center at the Institute of Living in Hartford, CT is is looking for African American participants aged 18-70. Participants must either be diagnosed with a psychiatric illness with psychosis (Schizophrenia, Bipolar Disorder or Schizoaffective Disorder) or have no history of psychiatric illness. Qualified participants will be asked to complete interviews, MRI, computer tests and blood draw. Compensation is provided.
Call Jen @ 860-545-7808 or Olivia @ 860-545-7794 for more information or to schedule an appointment.
Notice of an important study being conducted by the Institute of Living at Hartford Hospital
Have you been diagnosed with Major Depression, Bipolar Disorder or Schizophrenia? Have your symptoms not improved with your current medication? Dr. John Goethe at The Institute of Living/Hartford Hospital is offering screenings for participation in clinical research studies to assess whether investigational drugs may be useful, safe and well-tolerated for the treatment of these disorders. Participants will receive a study-related psychiatric evaluation and the study drugs at no cost. Compensation for time and travel is provided.
For more information, please contact:
Katherine Karbowski, Clinical Study Coordinator
Nationwide Recruitment: Bipolar Disorder (Adult) Research Study – Antidepressant (Rapid) Effects of Ketamine
Individuals who have been diagnosed with bipolar disorder may be able to participate in a trial designed to understand the causes of depression and rapid antidepressant response. Specifically, this trial is testing whether ketamine, a drug that affects glutamate in the brain will improve symptoms of depression within a matter of hours.
Individuals who are 18 to 65 years of age and have been diagnosed with bipolar disorder and previously failed to respond to treatment may be eligible for an inpatient trial designed to bring about a rapid antidepressant effect. After completion of the study the participant is transitioned back to a clinician in the community. In addition, all research participation is without cost and NIMHcovers all transportation costs from anywhere in the United States. Compensation is provided for study procedures.
To find out more information, please call 1-877-MIND-NIH (1-877-646-3644) or email email@example.com
National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services.
For more information on research conducted by the National Institute of Mental Health in Bethesda, MD: http://patientinfo.nimh.nih.gov